Subscribe To
Why proqr therapeutics stock got slammed again monday
Analysts are notably more bearish on the company following unhappy news about its leading drug candidat...
February 14, 2022, 6:23 pm
Why proqr therapeutics stock got slammed again monday
Analysts are notably more bearish on the company following unhappy news about its leading drug candidat...
February 14, 2022, 6:23 pm
Proqr (prqr) plunges as lead drug fails in phase ii/iii study
ProQR (PRQR) lead candidate sepofarsen did not meet primary and secondary goals in phase II/III study....
February 14, 2022, 5:46 pm
Proqr (prqr) plunges as lead drug fails in phase ii/iii study
ProQR (PRQR) lead candidate sepofarsen did not meet primary and secondary goals in phase II/III study....
February 14, 2022, 5:46 pm
Proqr (prqr) plunges as lead drug fails in phase ii/iii study
ProQR (PRQR) lead candidate sepofarsen did not meet primary and secondary goals in phase II/III study....
February 14, 2022, 5:46 pm
5 short squeeze candidate to watch: aridis pharmaceuticals tops list, evgo, indonesia energy corp and more
Potential short squeeze plays gained steam in 2021, with new retail traders looking for the next huge move. A short squeeze can occur when a heavily s...
February 14, 2022, 10:40 am
5 short squeeze candidate to watch: aridis pharmaceuticals tops list, evgo, indonesia energy corp and more
Potential short squeeze plays gained steam in 2021, with new retail traders looking for the next huge move. A short squeeze can occur when a heavily s...
February 14, 2022, 10:40 am
5 short squeeze candidate to watch: aridis pharmaceuticals tops list, evgo, indonesia energy corp and more
Potential short squeeze plays gained steam in 2021, with new retail traders looking for the next huge move. A short squeeze can occur when a heavily s...
February 14, 2022, 10:40 am
Novavax says its covid-19 vaccine candidate had a 80% efficacy rate in teens
Shares of Novavax Inc. NVAX, -4.13% gained 2.5% in premarket trading on Friday, the day after the company said its experimental COVID-19 vaccine had a...
February 11, 2022, 8:42 am
Novavax says its covid-19 vaccine candidate had a 80% efficacy rate in teens
Shares of Novavax Inc. NVAX, -4.13% gained 2.5% in premarket trading on Friday, the day after the company said its experimental COVID-19 vaccine had a...
February 11, 2022, 8:42 am
Novavax says its covid-19 vaccine candidate had a 80% efficacy rate in teens
Shares of Novavax Inc. NVAX, -4.13% gained 2.5% in premarket trading on Friday, the day after the company said its experimental COVID-19 vaccine had a...
February 11, 2022, 8:42 am
Phathom pharma's digestive disease candidate meets primary goal in mid-stage study
Phathom Pharmaceuticals Inc PHAT reported topline results from the PHALCON-NERD Phase 2 study of vonoprazan as an on-demand therapy to relieve episod...
February 10, 2022, 10:02 am
Phathom pharma's digestive disease candidate meets primary goal in mid-stage study
Phathom Pharmaceuticals Inc PHAT reported topline results from the PHALCON-NERD Phase 2 study of vonoprazan as an on-demand therapy to relieve episod...
February 10, 2022, 10:02 am
Phathom pharma's digestive disease candidate meets primary goal in mid-stage study
Phathom Pharmaceuticals Inc PHAT reported topline results from the PHALCON-NERD Phase 2 study of vonoprazan as an on-demand therapy to relieve episod...
February 10, 2022, 10:02 am
Molecular partners, novartis submit emergency use authorization request for ensovibep for covid-19
Molecular Partners AG MOLN and its partner Novartis AG NVS, have requested FDA Emergency Use Authorization (EUA) for ensovibep, a DARPin antivira...
February 10, 2022, 7:13 am
Molecular partners, novartis submit emergency use authorization request for ensovibep for covid-19
Molecular Partners AG MOLN and its partner Novartis AG NVS, have requested FDA Emergency Use Authorization (EUA) for ensovibep, a DARPin antivira...
February 10, 2022, 7:13 am
Molecular partners, novartis submit emergency use authorization request for ensovibep for covid-19
Molecular Partners AG MOLN and its partner Novartis AG NVS, have requested FDA Emergency Use Authorization (EUA) for ensovibep, a DARPin antivira...
February 10, 2022, 7:13 am
Silence therapeutics posts first human data for cardiovascular candidate
Silence Therapeutics plc SLN showed that its RNAi technology could reduce a patient's lp(a) levels by 98% at a high dose. Get the Inside Access Trad...
February 9, 2022, 3:35 pm
Silence therapeutics posts first human data for cardiovascular candidate
Silence Therapeutics plc SLN showed that its RNAi technology could reduce a patient's lp(a) levels by 98% at a high dose. Get the Inside Access Trad...
February 9, 2022, 3:35 pm
Silence therapeutics posts first human data for cardiovascular candidate
Silence Therapeutics plc SLN showed that its RNAi technology could reduce a patient's lp(a) levels by 98% at a high dose. Get the Inside Access Trad...
February 9, 2022, 3:35 pm